- cross-posted to:
- medicine@mander.xyz
- cross-posted to:
- medicine@mander.xyz
This is an automated archive made by the Lemmit Bot.
The original was posted on /r/science by /u/maximum_cats on 2023-11-11 14:59:18.
Original Title: Novo Nordisk study finds that semaglutide (Wegovy) reduces risk of serious cardiovascular events such as heart attacks by 20% in overweight patients with a history of cardiovascular disease and no history of diabetes
You must log in or register to comment.